K. Yunomae

Erratum: "Contribution of P-glycoprotein to the enhancing effects of dimethyl-β-cyclodextrin on oral bioavailability of tacrolimus" (The Journal of Pharmacology and Experimental Therapeutics (2001) 297 (547-555))

F. Hirayama, K. Uekama, H. Arima, 2001 .

Contribution of Cholesterol and Phospholipids to Inhibitory Effect of Dimethyl-β-Cyclodextrin on Efflux Function of P-Glycoprotein and Multidrug Resistance-Associated Protein 2 in Vinblastine-Resistant Caco-2 Cell Monolayers

Hidetoshi Arima, F. Hirayama, K. Uekama, 2004, Pharmaceutical Research.

Involvement of cholesterol in the inhibitory effect of dimethyl‐β‐cyclodextrin on P‐glycoprotein and MRP2 function in Caco‐2 cells

Hidetoshi Arima, F. Hirayama, K. Uekama, 2003, FEBS letters.

Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.

F. Hirayama, K. Uekama, H. Arima, 2001, Journal of pharmaceutical sciences.

Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.

F. Hirayama, K. Uekama, H. Arima, 2001, The Journal of pharmacology and experimental therapeutics.

Effects of phosphodiesterase (PDE) inhibitors on human ether‐a‐go‐go related gene (hERG) channel activity

Shinichi Nagayama, G. Kito, K. Fukuzaki, 2007, Journal of applied toxicology : JAT.

Immunogenicity of recombinant measles vaccine expressing fusion protein of respiratory syncytial virus in cynomolgus monkeys

T. Nakayama, K. Yunomae, Akihito Sawada, 2018, Microbiology and immunology.